Patents by Inventor Sophie Lehar

Sophie Lehar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel Th2-specific molecules and uses thereof
    Publication number: 20050202013
    Abstract: Novel Th2-specific polypeptides, proteins, and nucleic acid molecules are disclosed. In addition to isolated, full-length Th2-specific proteins, the invention further provides isolated Th2-specific fusion proteins, antigenic peptides, and anti-Th2-specific antibodies. The invention also provides Th2-specific nucleic acid molecules, recombinant expression vectors containing a nucleic acid molecule of the invention, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a Th2-specific gene has been introduced or disrupted. Diagnostic, screening, and therapeutic methods utilizing compositions of the invention are also provided.
    Type: Application
    Filed: May 3, 2005
    Publication date: September 15, 2005
    Inventors: Anthony Coyle, Stephen Manning, Sophie Lehar, Jose-Carlos Gutierrez-Ramos
  • Novel Th2-specific molecules and uses thereof
    Publication number: 20020164697
    Abstract: Novel Th2-specific polypeptides, proteins, and nucleic acid molecules are disclosed. In addition to isolated, full-length Th2-specific proteins, the invention further provides isolated Th2-specific fusion proteins, antigenic peptides, and anti-Th2-specific antibodies. The invention also provides Th2-specific nucleic acid molecules, recombinant expression vectors containing a nucleic acid molecule of the invention, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a Th2-specific gene has been introduced or disrupted. Diagnostic, screening, and therapeutic methods utilizing compositions of the invention are also provided.
    Type: Application
    Filed: November 20, 2001
    Publication date: November 7, 2002
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Anthony J. Coyle, Stephen Manning, Sophie Lehar, Jose-Carlos Gutierrez-Ramos
  • TH2-specific gene
    Patent number: 6190909
    Abstract: The present invention relates to the discovery, identification and characterization of nucleic acids that encode a novel protein differentially expressed within the TH2 cell subpopulation (hereinafter referred to as STIF).
    Type: Grant
    Filed: June 25, 1997
    Date of Patent: February 20, 2001
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Doug Levinson, Wei Gu, Sophie Lehar